Cardiologist: Bruce E. Lewis, MD | Loyola Medicine

Bruce E. Lewis, MD

Bruce E. Lewis, MD

Medicine

Cardiology
Professor

Languages Spoken

English, Spanish

Clinical Expertise

  • Vascular Intervention

About Dr. Lewis

Interests
Basketball, Tennis, Gardening

Medical Education

Medical School
Rush Medical College of Rush University
Residency
Rush-Presbyterian-St. Luke's Medical Center - Internal Medicine: General
Fellowship
  • Loyola University Medical Center - Cardiology

Board Certification

American Board of Internal Medicine
Cardiovascular Disease, American Board of Internal Medicine Subspecialty, Cardiology
Interventional Cardiology, American Board of Internal Medicine Subspecialty

Research

  • Endovascular Repair of Bilateral Internal Mammary Artery Aneurysms in a Patient with Marfan Syndrome-A Case Report Alhawasli, H.; Darki, A.; Lewis, B. E., The International journal of angiology : official publication of the International College of Angiology, Inc
  • ATA Practice Guidelines for Live On Demand Primary and Urgent Care, Gough, F.; Budhrani, S.; Cohn, E.; Dappen, A.; Leenknecht, C.; Lewis, B.; Mulligan, D. A.; Randall, D.; Rheuban, K.; Roberts, L.; Shanahan, T. J.; Webster, K.; Krupinski, E. A.; Bashshur, R.; Bernard, J., Telemedicine journal and e-health : the official journal of the American Telemedicine Association
  • Comparison of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction during and prior to availability of an in-house STEMI system: early experience and intermediate outcomes of the HARRT program for achieving routine D2B times <60 minutes Nguyen, B.; Fennessy, M.; Leya, F.; Nowak, W.; Ryan, M.; Freeberg, S.; Gill, J.; Dieter, R. S.; Steen, L.; Lewis, B.; Cichon, M.; Probst, B.; Jarotkiewicz, M.; Wilber, D.; Lopez, J. J., Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
View All ResearchShow Less
  • The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease Kuy, S.; Dua, A.; Chappidi, R.; Seabrook, G.; Brown, K. R.; Lewis, B.; Rossi, P. J.; Lee, C. J., Vascular
  • An open label non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers., Gomes, M.; Ramacciotti, E.; Hoppensteadt, D.; Walenga, J. M.; Lewis, B.; Thethi, I.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting. Dieter, R. S.; Darki, A.; Nanjundappa, A.; Chhokar, V. S.; Khadim, G.; Morshedi-Meibodi, A.; Freihage, J. H.; Steen, L.; Lewis, B.; Leya, F., American Journal of Cardiology
  • Argatroban in percutaneous coronary indications Iqbal, O.; Adiguzel, C.; Lewis, B. E.; Cunanan, J.; Fareed, J., Seminars in Thrombosis and Hemostasis
  • Femoral angiogram prior to arteriotomy closure device does not reduce vascular complications in patients undergoing cardiac catheterization. Ramana, R. K.; Singh, A.; Dieter, R. S.; Moran, J. F.; Steen, L.; Lewis, B. E.; Leya, F., Journal of interventional cardiology
  • Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Ramana, R. K.; Ronan, A.; Cohoon, K.; Homan, D.; Sutherland, J.; Steen, L.; Liu, J.; Loeb, H.; Lewis, B. E., Catheterization & Cardiovascular Interventions
  • Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin Ramana, R. K.; Lewis, B. E., Vascular Health & Risk Management
  • Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition. Kelton, J. G.; Hursting, M. J.; Heddle, N.; Lewis, B. E., Blood Coagulation & Fibrinolysis
  • Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Lewis, B. E.; Hursting, M. J., Expert Review of Cardiovascular Therapy
  • Invasive assessment of mitral regurgitation: comparison of hemodynamic parameters. Freihage, J. H.; Joyal, D.; Arab, D.; Dieter, R. S.; Loeb, H. S.; Steen, L.; Lewis, B.; Liu, J. C.; Leya, F., Catheterization & Cardiovascular Interventions
  • Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease. Joyal, D.; Leya, F.; Al Chekakie, M. O.; Arab, D.; Dieter, R. S.; Morshedi-Meibodi, A.; Lewis, B.; Steen, L.; Fareed, J.; Hoppenstead, D.; Akar, J. G., Coronary artery disease
  • The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis. Joyal, D.; Freihage, J. H.; Cohoon, K.; Tempelhof, M.; Leya, F.; Dieter, R. S.; Steen, L.; Lewis, B.; Arab, D., Journal of Invasive Cardiology
  • Troponin I levels in patients with preeclampsia. Joyal, D.; Leya, F.; Koh, M.; Besinger, R.; Ramana, R.; Kahn, S.; Jeske, W.; Lewis, B.; Steen, L.; Mestril, R.; Arab, D., American Journal of Medicine
  • Utility of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy in patients with renal insufficiency. Reddy, P. R.; Dieter, R. S.; Das, P.; Steen, L. H.; Lewis, B. E.; Leya, F. S., Journal of cardiac failure
  • Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunction Ramana, R. K.; Joyal, D.; Arab, D.; Dieter, R. S.; Steen, L.; Lewis, B.; Leya, F., Journal of Invasive Cardiology
  • Effects of argatroban therapy demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia, Lewis, B. E.; Wallis, D. E.; Hursting, M. J.; Levine, R. L.; Leya, F., Chest
  • Antiplatelet therapy in anticoagulated patients requiring coronary intervention Arab, D.; Lewis, B.; Cho, L.; Steen, L.; Joyal, D.; Leya, F., Journal of Invasive Cardiology
  • Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era Ramana, R. K.; Arab, D.; Joyal, D.; Steen, L.; Cho, L.; Lewis, B.; Liu, J.; Loeb, H.; Leya, F., Journal of Invasive Cardiology
  • The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. Leya, F. S.; Arab, D.; Joyal, D.; Shioura, K. M.; Lewis, B. E.; Steen, L. H.; Cho, L., Journal of the American College of Cardiology
  • Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention. Cho, L.; Lewis, B. E.; Steen, L. H.; Leya, F. S., Cardiology
  • Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use. Tobu, M.; Iqbal, O.; Ma, Q.; Schultz, C.; Jeske, W.; Hoppensteadt, D.; Lewis, B.; Fareed, D.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • New catheter design for cannulation of the anomalous right coronary artery arising from the left sinus of valsalva. Qayyum, U.; Leya, F.; Steen, L.; Sochanski, M.; Grassman, E.; Cho, L.; Lewis, B., Catheterization & Cardiovascular Interventions
  • Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia Cochran, K.; DeMartini, T. J.; Lewis, B. E.; O'Brien, J.; Steen, L. H.; Grassman, E. D.; Leya, F., Journal of Invasive Cardiology
  • Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia Liu, J. C.; Lewis, B. E.; Steen, L. H.; Grassman, E. D.; Bakhos, M.; Blakeman, B.; Wrona, L.; Leya, F., The American Journal of Cardiology
  • Bleeding complications with glycoprotein IIb/IIIa inhibitors Iqbal, O.; Walenga, J. M.; Lewis, B. E.; Bakhos, M., Drugs of today (Barcelona, Spain : 1998)